Navigation Links
ResMed Inc. to Present at Upcoming Conferences in June
Date:5/27/2009

SAN DIEGO, May 27 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that it will be presenting at three upcoming conferences. David Pendarvis, SVP Organization Development and General Counsel will present at the William Blair Growth Stock Conference at the Four Seasons in Chicago on June 10, 2009 at 9:20 a.m. US Central Time. Kieran Gallahue, President and CEO will present at the Jefferies Third Annual Healthcare Conference at the Mandarin Oriental in New York City on June 18, 2009 at 9:30 a.m. US Eastern Time. David Pendarvis, SVP Organization Development and General Counsel will present at the Wachovia/Wells Fargo Annual Mid-Year Equity Conference at the Intercontinental Boston Hotel in Boston on June 23, 2009 at 4:00 p.m. US Eastern Time.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at http://investor.resmed.com. Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at www.resmed.com.

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.


'/>"/>
SOURCE ResMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ResMed Inc. to Present at Upcoming Healthcare Conferences in May
2. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results
3. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2008
4. ResMed to Webcast Second Quarter 2009 Earnings Conference Call
5. ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008
6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
7. ResMed to Webcast Third Quarter 2008 Earnings Conference Call
8. RESMED to Webcast Second Quarter 2008 Earnings Conference Call
9. ResMed to Webcast First Quarter 2008 Earnings Conference Call
10. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
11. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a ... Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip ... in association with efforts by the American College of Surgeons, U.S. Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: